Comparison of treatment invasiveness between upfront debulking surgery versus interval debulking surgery following neoadjuvant chemotherapy for stage III/IV ovarian, tubal, and peritoneal cancers in a phase III randomised trial: Japan Clinical Oncology Group Study JCOG0602
European Journal of Cancer2016Vol. 64, pp. 22–31
Citations Over TimeTop 1% of 2016 papers
Takashi Onda, Toyomi Satoh, Toshiaki Saito, Takahiro Kasamatsu, Toru Nakanishi, Kenichi Nakamura, Masashi Wakabayashi, Kazuhiro Takehara, Motoaki Saito, Kimio Ushijima, Hiroaki Kobayashi, Kei Kawana, Harushige Yokota, Masashi Takano, Nobuhiro Takeshima, Yoh Watanabe, Nobuo Yaegashi, Ikuo Konishi, Toshiharu Kamura, Hiroyuki Yoshikawa
Related Papers
- Evaluation of carboplatin pharmacokinetics in the absence and presence of paclitaxel.(1996)
- → Treatment of Wilms tumor using carboplatin compared to therapy without carboplatin(2014)6 cited
- → The changing role of “second-look” laparotomy in the management of epithelial carcinoma of the ovary(1982)30 cited
- → Optimal debulking following chemotherapy of advanced‐stage epithelial ovarian carcinoma(1989)2 cited
- → Electrochemical Detection of Carboplatin-Resistance in Ovarian Cancer(2022)